Atomoxetine Hydrochloride

Atomoxetine is a norepinephrine reuptake inhibitor approved for the treatment of attention deficit hyperactivity disorder (ADHD). The brand name is Strattera. The initial therapeutic effects of atomoxetine usually take 2–4 weeks to become apparent. There has been some suggestion that atomoxetine might be a helpful adjunct in people with major depression, especially in cases where ADHD occurs comorbidly to major depression.

Product information

CAS Number: 82248-59-7

Molecular Weight: 291.82

Formula: C17H22ClNO

Synonym:

Tomoxetine hydrochloride

LY 139603

(R)-Tomoxetine hydrochloride

Chemical Name: methyl[(3R)-3-(2-methylphenoxy)-3-phenylpropyl]amine hydrochloride

Smiles: Cl.CC1=CC=CC=C1O[C@H](CCNC)C1C=CC=CC=1

InChiKey: LUCXVPAZUDVVBT-UNTBIKODSA-N

InChi: InChI=1S/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/m1./s1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.